CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene

被引:0
|
作者
Yun-Qing Bai
Satoshi Miyake
Takehisa Iwai
Yasuhito Yuasa
机构
[1] Graduate School of Medicine and Dentistry,Department of Molecular Oncology
[2] Tokyo Medical and Dental University,Department of Surgery
[3] Graduate School of Medicine and Dentistry,undefined
[4] Tokyo Medical and Dental University,undefined
来源
Oncogene | 2003年 / 22卷
关键词
CDX2; transcription; p21/WAF1/CIP1;
D O I
暂无
中图分类号
学科分类号
摘要
The CDX2 homeobox transcription factor plays key roles in intestinal development and homeostasis. CDX2 is downregulated during colorectal carcinogenesis, whereas overexpression of CDX2 results in growth inhibition and differentiation of colon carcinoma and intestinal cells. However, the means by which CDX2 functions remain poorly understood. p21/WAF1/CIP1 is one of the cyclin-dependent kinase inhibitors. In addition to its role in cell cycle control, p21 plays critical roles in differentiation and tumor suppression. The overlapping in both the expression and function of CDX2 and p21 in the small intestine and colon strongly suggests a link between these two genes. By means of luciferase reporter and electrophoretic mobility shift assays, we show here that CDX2 transactivated and physically interacted with the promoter of p21 in a p53-independent manner. Moreover, overexpression of CDX2 increased the mRNA expression of p21 in HT-29 colon carcinoma cells, as demonstrated by reverse transcription–polymerase chain reaction. These data suggest that p21 is a transcriptional target of CDX2. Our results may thus provide a new mechanism underlying the functions of CDX2.
引用
收藏
页码:7942 / 7949
页数:7
相关论文
共 50 条
  • [21] p21(WAF1/CIP1) interacts with protein kinase CK2
    Gotz, C
    Wagner, P
    Issinger, OG
    Montenarh, M
    ONCOGENE, 1996, 13 (02) : 391 - 398
  • [22] Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues
    Ito, Y
    Kobayashi, T
    Takeda, T
    Komoike, Y
    Wakasugi, E
    Tamaki, Y
    Tsujimoto, M
    Matsuura, N
    Monden, M
    BRITISH JOURNAL OF CANCER, 1996, 74 (08) : 1269 - 1274
  • [23] Repair defect in p21(WAF1/CIP1) -/- human cancer cells
    McDonald, E
    Wu, GS
    Waldman, T
    ElDeiry, WS
    CANCER RESEARCH, 1996, 56 (10) : 2250 - 2255
  • [24] Relationship of p21 (waf1/cip1) and differentiation n chondrosarcoma cells
    Hiraoka, K
    Zenmyo, M
    Komiya, S
    Kawabata, R
    Yokouchi, M
    Suzuki, R
    Hamada, T
    Kato, S
    Nagata, K
    VIRCHOWS ARCHIV, 2002, 440 (03) : 285 - 290
  • [25] p21 (WAF1/CIP1) is required for the mitogenic response to intestinal resection
    Stern, LE
    Falcone, RA
    Kemp, CJ
    Erwin, CR
    Warner, BW
    JOURNAL OF SURGICAL RESEARCH, 2000, 90 (01) : 45 - 50
  • [26] P21 Waf1/Cip1 as a therapeutic target in breast and other cancers
    Weiss, RH
    CANCER CELL, 2003, 4 (06) : 425 - 429
  • [27] MOLECULAR ANALYSIS OF THE CIP1/WAF1 (P21) GENE IN DIVERSE TYPES OF HUMAN TUMORS
    WATANABE, H
    FUKUCHI, K
    TAKAGI, Y
    TOMOYASU, S
    TSURUOKA, N
    GOMI, K
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1263 (03): : 275 - 280
  • [28] P21 WAF1/CIP1 gene DNA sequencing and its expression in human osteosarcoma
    Liao, WM
    Zhang, CL
    Li, FB
    Zeng, BF
    Zeng, YX
    CHINESE MEDICAL JOURNAL, 2004, 117 (06) : 936 - 940
  • [29] p21(WAF1/CIP1) and terminal differentiation control of normal epithelia
    Missero, C
    Dotto, GP
    MOLECULAR AND CELLULAR DIFFERENTIATION, 1996, 4 (01): : 1 - 16
  • [30] Prognostic implications of p21 (Waf1/Cip1) immunolocalization in multiple myeloma
    Ohata, Masahiko
    Nakamura, Shinobu
    Fujita, Hiroyuki
    Isemura, Mamoru
    BIOMEDICAL RESEARCH-TOKYO, 2005, 26 (03): : 91 - 98